Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Munich - Delayed Quote EUR

Bayer AG (BAYA.MU)

Compare

5.25

0.00

(0.00%)

At close: February 21 at 8:00:43 AM GMT+1

BridgeBio price target raised to $49 from $48 at Scotiabank

Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the shares. BridgeBio recently announced its European partner Bayer (BAYRY) was granted a marketing authorization for transthyretin stabilizer acoramidis by the European Commission, which will treat adults with wild-type or variant transthyretin amyloidosis with cardiomyopathy, the analyst tells investors. The firm anticipates the EU launch of acoramidis in 1H25 w

TipRanks 10 days ago

BAYRY

BAYZF

BBIO
Bayer Secures End of Roundup Weedkiller Litigation in Australia

The German pharmaceutical and agricultural conglomerate said the Federal Court of Australia closed the last pending case in the country over whether its Roundup weedkiller causes cancer.

The Wall Street Journal last month

BAYRY

BAYZF
Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia

LEVERKUSEN, Germany, January 03, 2025--The Federal Court of Australia brought an end to the last Roundup™ case in Australia, closing all pending injury litigation there. The Court granted the plaintiffs’ request to discontinue the Fenton class action against Monsanto involving allegations related to Roundup™. This action follows the company’s earlier victory in the McNickle case in the same court.

Business Wire last month

BAYRY

BAYZF
Bayer Third Quarter 2024 Earnings: Misses Expectations

Bayer ( ETR:BAYN ) Third Quarter 2024 Results Key Financial Results Revenue: €9.97b (down 3.6% from 3Q 2023). Net loss...

Simply Wall St. 3 months ago

BAYRY

BAYZF
Trending tickers: Coinbase, Tesla, AstraZeneca, Metro Bank and SoftBank

The latest investor updates on stocks that are trending on Tuesday.

Yahoo Finance UK 3 months ago

OXINF

IFNNF

IFNNY
Stocks to watch next week: Burberry, SSE, Disney, Alibaba and AstraZeneca

Earnings preview of key companies reporting next week and what to look out for.

Yahoo Finance UK 3 months ago

VLXGF

IFMNF

TSN
The past five years for Bayer (ETR:BAYN) investors has not been profitable

We think intelligent long term investing is the way to go. But that doesn't mean long term investors can avoid big...

Simply Wall St. 3 months ago

BAYRY

BAYZF
Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 3 months ago

NGG

NGGTF

YUMC
Bayer's Roundup, Estée Lauder, H&R Block: Stocks In Focus

Bayer (BAYN.DE) stock surged Friday morning after a US appeals court ruled in favor of the pharmaceutical and biotech giant in a legal battle over claims that the herbicide Roundup is linked to cancer. Bank of America analysts downgraded beauty and skincare brand Estée Lauder's stock (EL) on consumer headwinds in China and the US. H&R Block (HRB) shares are soaring after topping its fiscal fourth quarter earnings estimates. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 6 months ago

EL

HRB

BAYRY
Trending tickers: Amazon, JD.com, Bayer and Applied Materials

The latest investor updates on stocks that are trending on Friday.

Yahoo Finance UK 6 months ago

JD

JDCMF

^GSPC
Further weakness as Bayer (ETR:BAYN) drops 3.3% this week, taking one-year losses to 49%

It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...

Simply Wall St. 8 months ago

BAYRY

BAYZF
Stocks to watch this week: Burberry, Vodafone, BT and Walmart

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 9 months ago

BAIDF

BIDU

^GSPC
Bayer CEO: Now is not the time to break the company up

Life sciences company Bayer (BAYRY, BAYN.DE) isn't breaking itself up right now. Bayer CEO Bill Anderson says, "This is not a good time to be... breaking up the firm," given the company's need to rebuild its pharmaceutical pipeline and battle the ongoing litigation stemming from the weedkiller Roundup. When it comes to the Roundup lawsuits, Bayer has "adequately provisioned" for the costs of those suits, Anderson says. Overall, "the fundamental fact is, that glyphosate, Roundup, is safe," Anderson states, adding that Bayer is "a scientifically-driven company and we have this litigation thing that's not scientific." On the pharmaceutical business, Anderson says the group is "in a bit of a transition phase." "We got a couple of major medicines that are losing patent protection over the next few years. So we are busy rebuilding the pipeline right now," he tells Yahoo Finance. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.

Yahoo Finance Video 11 months ago

BAYRY

BAYZF
Inflation: Over-the-counter drug prices leap year over year

Alongside other sectors of the consumer economy, nonprescription drug prices saw prices rise 9.3% year-over-year. The insurance industry, health insurance and auto insurance providers in particular, have been beset by inflationary challenges. Yahoo Finance Health Reporter Anjalee Khemlani details the price trends for over-the-counter drugs, referencing a statement from Bayer (BAYRY) from its third-quarter 2023 in relation to how pharmaceutical companies are trying to offset inflation. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.

Yahoo Finance Video 11 months ago

BAYRY

BAYZF

Performance Overview

Return	BAYA.MU	DAX P
YTD	+12.18%	+11.95%
1-Year	-27.77%	+30.20%
3-Year	-56.48%	+51.30%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bayer AG (BAYA.MU)

BridgeBio price target raised to $49 from $48 at Scotiabank

Bayer Secures End of Roundup Weedkiller Litigation in Australia

Bayer: Federal Court Brings an End to Roundup™ Litigation in Australia

Bayer Third Quarter 2024 Earnings: Misses Expectations

Trending tickers: Coinbase, Tesla, AstraZeneca, Metro Bank and SoftBank

Stocks to watch next week: Burberry, SSE, Disney, Alibaba and AstraZeneca

The past five years for Bayer (ETR:BAYN) investors has not been profitable

Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S

Bayer's Roundup, Estée Lauder, H&R Block: Stocks In Focus

Trending tickers: Amazon, JD.com, Bayer and Applied Materials

Further weakness as Bayer (ETR:BAYN) drops 3.3% this week, taking one-year losses to 49%

Stocks to watch this week: Burberry, Vodafone, BT and Walmart

Bayer CEO: Now is not the time to break the company up

Inflation: Over-the-counter drug prices leap year over year

Performance Overview